Icon Special and general specialist literatureSpecial scientific titles & generally understandable specialist literature
Icon Free shipping in EuropeFree shipping throughout Europe
Icon pay safelySecure payment via PayPal & bank transfer

    News - archive

    Select here - your selection will appear below

    Your selection

    "In recent years, patients with advanced end-stage heart failure have increased in numbers. The treatment consists of drug therapy, surgical therapy, mechanical support and heart transplantation. Due to the increasing shortage of organ donors, left ventricular assist devices (LVAD) are becoming the focus of clinical interest - not only as a bridge to heart transplantation, but more and more as an alternative to heart transplantation with destination therapy," PD Dr. Christian Heim (University Erlangen) and colleagues report in the new textbook "Extracorporeal Circulation". The experienced authors describe indications, applications and complications in detail. Additionally, future prospects are discussed:

    [...] read more

    As the reliance on mobile communication devices increases more and more in daily routines, it seems natural that people will also rely on this communication form when it comes to crisis situations - may it be as a witness, bystander or victim. From the standpoint of First Responders (FRs) and Public Protection and Disaster Relief (PPDR) organizations, it is therefore important, not only to be aware of this development, but also to take measure and develop procedures, guidelines and tools to incorporate (mobile) online communication as an additional information and communication channel. Prof. Dr. Silke Schmidt, Dr. Daniela Knuth and colleagues provide research and guidelines in the textbook "iSAR+ New Media in Crisis Situations".

    [...] read more

    The human recombinant anti-SARS-CoV-2 antibody COR-101 was developed in close cooperation of Technische Universität Braunschweig, the Helmholtz Centre for Infection Research (HZI) and the biotech company YUMAB GmbH in Braunschweig. The antibody is currently undergoing phase Ib/II clinical trials for the treatment of moderate to severe COVID-19 by CORAT Therapeutics GmbH. The story of the discovery and development of this antibody was now published in the Journal "Cell Reports".

    [...] read more

    Suicide bombings are causing a rising number of causalties worldwide. These attacks are characterized by the ability of terrorist organizations to detonate high powered explosive devices in proximity to large groups of civilians. The devastating effects of heavy shrapnel and blast wave combine to cause a wide array of injuries. Severe injury to gas-containing organs is common, multiple entry sites are frequent, and severe soft tissue damage is widespread. Thoracic, abdominal and pelvis-traversing missiles are not uncommon among survivors. Triage and initial evaluation are essential in these chaotic scenarios. Israeli experts in all fields of medicine provide pragmatic knowledge, how to treat and manage the victims: The textbook "Terror and Medicine" is based and focused on practical experience.

    [...] read more

    Many organ transplantations fail due Covid-19-infection. S. Yin and colleagues (Chengdu/China) evaluated 59 studies with 7071 Covid-19-positive patients and presented the results during the current American Transplant Congress (virtual):

    [...] read more
    Icon Special and general specialist literatureSpecial scientific titles & generally understandable specialist literature
    Icon Free shipping in EuropeFree shipping throughout Europe
    Icon pay safelySecure payment via PayPal & bank transfer